Nyxoah SA Long Term Debt 2021-2024 | NYXH

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Nyxoah SA long term debt from 2021 to 2024. Long term debt can be defined as the sum of all long term debt fields.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Nyxoah SA long term debt from 2021 to 2024. Long term debt can be defined as the sum of all long term debt fields.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$37.7B
Tempus AI (TEM)	$8B
Hims & Hers Health (HIMS)	$7B
Inspire Medical Systems (INSP)	$5.7B
IRhythm Technologies (IRTC)	$3.5B
Privia Health (PRVA)	$2.7B
Enovis (ENOV)	$2.7B
Azenta (AZTA)	$2.4B
Clover Health Investments (CLOV)	$2.2B
Omnicell (OMCL)	$2.1B
Schrodinger (SDGR)	$1.8B
10x Genomics (TXG)	$1.8B
Phreesia (PHR)	$1.7B
Butterfly Network (BFLY)	$748M
Standard BioTools (LAB)	$588M
Talkspace (TALK)	$537M
Fulgent Genetics (FLGT)	$515M
TruBridge (TBRG)	$362M
Health Catalyst (HCAT)	$343M
SOPHiA GENETICS SA (SOPH)	$235M
Pulmonx (LUNG)	$230M
American Well (AMWL)	$169M
EUDA Health Holdings (EUDA)	$96M
P3 Health Partners (PIII)	$69M
CareCloud (CCLD)	$58M
HeartBeam (BEAT)	$58M
111 (YI)	$47M
Outset Medical (OM)	$44M
Zepp Health (ZEPP)	$42M
SHL Telemedicine (SHLT)	$42M